Peptide Therapy for Anxiety and Depression: A Research-Based Overview

The connection between peptides and mood regulation goes back to the discovery of endorphins in the 1970s. Researchers found that the body produces small protein fragments that act on opioid receptors, producing pain relief and a sense of well-being. This was the first evidence that peptides could directly influence how you feel. Selank was developed at the Institute of Molecular Genetics in Moscow in the early 2000s. It's based on the naturally occurring peptide tuftsin, which plays a role in immune function. Researchers modified tuftsin to enhance its neurological effects and found that the resulting peptide had significant anxiolytic properties. Selank has been approved in Russia as a treatment for generalized anxiety disorder and has been used clinically there for over a decade. BPC-157's connection to mood came later and more accidentally. Users taking BPC-157 for gut injuries started reporting mood improvements, particularly reduced anxiety and a sense of emotional stability. Researchers investigating these reports found that BPC-157 modulates several neurotransmitter systems, including dopamine, serotonin, and GABA. The broader interest in peptide therapy for mental health accelerated in 2025 and 2026 as the wellness and biohacking communities expanded. People who had success with peptides for physical conditions began asking what else these molecules could address.

Selank works primarily through the GABA system. It enhances GABAergic signaling, which is the same system targeted by benzodiazepines like Xanax. The difference is that selank doesn't produce sedation, cognitive impairment, or dependency. It also modulates the expression of brain-derived neurotrophic factor (BDNF) and influences interleukin-6, an inflammatory cytokine that's elevated in many people with depression. BPC-157 affects multiple neurotransmitter systems simultaneously. In animal studies, it reversed serotonin syndrome (excess serotonin) and also corrected serotonin depletion. It normalizes dopamine function, which is relevant because dopamine dysregulation is implicated in both depression and anxiety. BPC-157 also promotes gut-brain axis communication through vagus nerve signaling, which is a newer area of psychiatric research. Selank and semax are often discussed together because they're both Russian-developed neurological peptides. Selank targets anxiety. Semax targets cognitive function and has some mood-stabilizing effects. The combination addresses both the emotional and cognitive symptoms that often co-occur in depression. Thymosin alpha-1 has an indirect role. It modulates the immune system, and there's growing evidence that neuroinflammation contributes to treatment-resistant depression. By reducing systemic inflammation, thymosin alpha-1 may improve the brain's neurochemical environment.

Selank reduces the subjective experience of anxiety. Users describe it as taking the edge off without making them feel drugged or disconnected. The effect is subtle compared to benzodiazepines. There's no high, no drowsiness, and no impaired coordination. What's left is a baseline reduction in the background hum of worry. BPC-157's mood effects are more variable. Some users report a significant lift in depressive symptoms, describing it as feeling “normal again.“ Others notice more subtle changes, like improved stress resilience or better sleep quality. The mood effects seem to be more pronounced in people who also have gut issues, which makes sense given BPC-157's primary action on the gastrointestinal tract. Neither peptide works like an SSRI or SNRI. They don't block neurotransmitter reuptake. The mechanism is more about restoring balance in systems that have been disrupted. This means they may work better for anxiety and depression that has a clear physiological component (inflammation, gut dysfunction, post-concussion) rather than purely psychological origins.

A user on r/Peptides described their selank experience: “I've had generalized anxiety for 15 years. Tried every SSRI out there. Started selank nasal spray at 250mcg twice a day. First week I didn't notice much. By week two, I realized I wasn't doing my usual spiral of worrying about everything. It wasn't gone completely but the volume was turned way down. No side effects except a slightly stuffy nose sometimes.“ Another user on r/Peptides shared their BPC-157 experience for depression: “I started BPC-157 for a shoulder injury and noticed after about 3 weeks that my mood was significantly better. I've had treatment-resistant depression for 8 years. This wasn't a manic high or anything artificial. I just felt like the fog had lifted enough to function. I could actually enjoy things again. Not sure if it's the gut-brain connection or what, but it worked for me.“ The pattern in user reports is that these peptides produce a subtle, sustainable improvement rather than a dramatic shift. People don't describe feeling euphoric or different. They describe feeling like themselves again, or like the volume on their anxiety has been turned down.

• Reduced baseline anxiety, the constant background worry becomes quieter
• Improved stress resilience, situations that triggered panic become more manageable
• Better emotional regulation, less reactive to minor stressors
• Improved sleep quality as anxiety decreases
• Possible reduction in depressive symptoms, especially those with inflammatory or gut-related components
• No sedation, cognitive impairment, or dependency risk with selank

Selank is the primary peptide for anxiety. It's typically used as a nasal spray at 250 to 500mcg once or twice daily. It pairs well with BPC-157 when both anxiety and depression are present. BPC-157 addresses the gut-brain axis and dopamine/serotonin normalization. It's especially relevant for people whose mood issues coexist with gut problems, which is more common than most people realize. Semax complements selank by targeting cognitive symptoms. Depression and anxiety often come with brain fog, poor concentration, and cognitive fatigue. Semax addresses these directly. DSIP (delta sleep-inducing peptide) may help when sleep disruption is a major factor. Poor sleep both causes and worsens anxiety and depression. DSIP promotes deeper, more restorative sleep. Thymosin alpha-1 is worth considering when inflammation is a suspected contributor. If blood work shows elevated inflammatory markers, thymosin alpha-1 can address the systemic inflammation that may be driving treatment resistance.